MTN-015 study population of participants from MTN-003 parent protocol.

<p>MTN-015 study population of participants from MTN-003 parent protocol.</p

Unadjusted Cox proportional hazards model for time to first CD4 ≤ 350 and time to composite disease progression endpoint.

<p>Unadjusted Cox proportional hazards model for time to first CD4 ≤ 350 and time to composite disease progression endpoint.</p

Linear mixed effects model comparing HIV-1 RNA (log₁₀) and CD4 T-cell counts between the first result 90 days or more after the estimated HIV seroconversion date (intercept) and the 12-month visit (slope) by study arm.

<p>Linear mixed effects model comparing HIV-1 RNA (log₁₀) and CD4 T-cell counts between the first result 90 days or more after the estimated HIV seroconversion date (intercept) and the 12-month visit (slope) by study arm.</p

Participant characteristics¹.

<p>¹Note that the denominators used to calculate percentages throughout this table may vary owing to small amounts of missing data for individual variables and may not sum to 100% due to rounding.</p><p>² Based on a reactive result to the syphilis screening and a positive confirmatory test result. Note that participants testing positive at screening were provided treatment according to WHO guidelines.</p><p>Participant characteristics<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0128857#t002fn001" target="_blank">¹</a>.</p

Summary of subjects screened.

<p>Summary of subjects screened.</p